Prediction of outcome in multiple sclerosis based on multivariate models
- PMID: 7836963
- DOI: 10.1007/BF00920623
Prediction of outcome in multiple sclerosis based on multivariate models
Abstract
An incidence cohort of 308 multiple sclerosis patients was followed up repeatedly during at least 25 years of disease. In the patients with acute onset, multivariate survival analyses were performed and predictive models created. The endpoints DSS 6 and start of progressive disease were used. A number of variables were tested. The most important of these for prediction and therefore included in these models were: age at onset, sex, degree of remission after relapse, mono- or polyregional symptoms, type of affected nerve fibres, number of affected neurological systems. The relapse rate did not correlate with prognosis. In the predictive models, coefficients and risk ratios are provided that can be used for calculating the risk of progression and DSS 6 or to predict the median time for these endpoints in individual patients. It was also found that the risk of progression is not constant, but has a maximum a certain time after disease onset. For a patient with early onset, the risk is low in the beginning, but reaches a maximum level, which is several times higher, after about 15 years. The patient with a late onset has a much higher risk of endpoint immediately after onset, but reaches the maximum in a few years, and after that the risk decreases.
Similar articles
-
Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis.Mult Scler. 2003 Jun;9(3):260-74. doi: 10.1191/1352458503ms914oa. Mult Scler. 2003. PMID: 12814173
-
The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.Brain. 1999 Apr;122 ( Pt 4):625-39. doi: 10.1093/brain/122.4.625. Brain. 1999. PMID: 10219776
-
Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.Brain. 1993 Feb;116 ( Pt 1):117-34. doi: 10.1093/brain/116.1.117. Brain. 1993. PMID: 8453453
-
A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.Brain. 2012 Mar;135(Pt 3):900-11. doi: 10.1093/brain/awr336. Brain. 2012. PMID: 22366800
-
Mitoxantrone: a review of its use in multiple sclerosis.CNS Drugs. 2004;18(6):379-96. doi: 10.2165/00023210-200418060-00010. CNS Drugs. 2004. PMID: 15089110 Review.
Cited by
-
Smouldering multiple sclerosis: the 'real MS'.Ther Adv Neurol Disord. 2022 Jan 25;15:17562864211066751. doi: 10.1177/17562864211066751. eCollection 2022. Ther Adv Neurol Disord. 2022. PMID: 35096143 Free PMC article. Review.
-
Sex-related factors in multiple sclerosis susceptibility and progression.Nat Rev Neurol. 2012 Mar 27;8(5):255-63. doi: 10.1038/nrneurol.2012.43. Nat Rev Neurol. 2012. PMID: 22450508 Free PMC article. Review.
-
Sex chromosome contributions to sex differences in multiple sclerosis susceptibility and progression.Mult Scler. 2018 Jan;24(1):22-31. doi: 10.1177/1352458517737394. Mult Scler. 2018. PMID: 29307297 Free PMC article.
-
Clinical characteristics of patients with late-onset multiple sclerosis.J Neurol. 2008 May;255(5):697-702. doi: 10.1007/s00415-008-0778-x. Epub 2008 Feb 19. J Neurol. 2008. PMID: 18283394
-
Systematic review of prediction models in relapsing remitting multiple sclerosis.PLoS One. 2020 May 26;15(5):e0233575. doi: 10.1371/journal.pone.0233575. eCollection 2020. PLoS One. 2020. PMID: 32453803 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical